Insider Sale: Chief Medical Officer of $PCRX (PCRX) Sells 879 Shares
Insider Sale: Chief Medical Officer of $PCRX (PCRX) Sells 879 Shares
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.JONATHAN SLONIN, the Chief Medical Officer of $PCRX ($PCRX), sold 879 shares of the company on 01-06-2025. We received data on the trade from a recent SEC filing. This was a sale of approximately 0.9% of their shares. Following this trade, they now own 93,443 shares of $PCRX stock.
约翰·斯洛宁（JONATHAN SLONIN），$PCRX（$PCRX）的首席医疗官，于2025年1月6日出售了879股该公司的股票。我们从最近的SEC备案中收到了有关这笔交易的数据。这笔交易大约占他们持有股份的0.9%。在这次交易之后，他们现在持有93,443股$PCRX股票。
$PCRX Insider Trading Activity
$PCRX内部交易活动
$PCRX insiders have traded $PCRX stock on the open market 10 times in the past 6 months. Of those trades, 6 have been purchases and 4 have been sales.
$PCRX内部人士在过去6个月内在公开市场上交易了10次$PCRX股票。在这些交易中，有6次是购买，4次是销售。
Here's a breakdown of recent trading of $PCRX stock by insiders over the last 6 months:
以下是过去6个月内部人士对$PCRX股票的近期交易汇总：
- JONATHAN SLONIN (Chief Medical Officer) has traded it 2 times. They made 0 purchases and 2 sales, selling 1,824 shares.
- DARYL GAUGLER (Chief Operating Officer) has traded it 2 times. They made 0 purchases and 2 sales, selling 1,000 shares.
- MARCELO BIGAL has traded it 2 times. They made 2 purchases, buying 4,912 shares and 0 sales.
- LAURA BREGE purchased 1,000 shares.
- MICHAEL J. YANG purchased 2,000 shares.
- MARK FROIMSON purchased 1,400 shares.
- FRANK D. LEE (Chief Executive Officer) purchased 8,264 shares.
- 约翰·斯洛宁（首席医疗官）交易了2次。他们没有购买，进行了2次销售，出售了1,824股。
- 达里尔·高格勒（首席运营官）交易了2次。他们没有购买，进行了2次销售，出售了1,000股。
- 马塞洛·比加尔（MARCELO BIGAL）交易了2次。他们进行了2次购买，购买了4,912股，0次销售。
- 劳拉·布雷格（LAURA BREGE）购买了1,000股。
- MICHAEL J. YANG 购买了2000股。
- MARk FROIMSON 购买了1400股。
- FRANk D. LEE （首席执行官）购买了8264股。
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
要跟踪内部交易，请查看Quiver Quantitative的内部交易特斯拉-仪表。
$PCRX Hedge Fund Activity
$PCRX 对冲基金活动
We have seen 131 institutional investors add shares of $PCRX stock to their portfolio, and 154 decrease their positions in their most recent quarter.
我们已经看到131家机构投资者在最近一个季度增加了PCRX股票的持仓，而154家减少了其持仓。
Here are some of the largest recent moves:
以下是最近的一些重大变动：
- PACER ADVISORS, INC. added 2,799,434 shares (+129.4%) to their portfolio in Q3 2024
- FRONTIER CAPITAL MANAGEMENT CO LLC removed 1,836,873 shares (-100.0%) from their portfolio in Q3 2024
- MACQUARIE GROUP LTD removed 1,567,013 shares (-100.0%) from their portfolio in Q3 2024
- D. E. SHAW & CO., INC. added 1,476,508 shares (+307.3%) to their portfolio in Q3 2024
- STEPHENS INVESTMENT MANAGEMENT GROUP LLC removed 1,371,561 shares (-100.0%) from their portfolio in Q3 2024
- ARROWSTREET CAPITAL, LIMITED PARTNERSHIP added 1,099,216 shares (+2058.1%) to their portfolio in Q3 2024
- MORGAN STANLEY added 1,079,724 shares (+209.2%) to their portfolio in Q3 2024
- PACER ADVISORS, INC. 在2024年第三季度增加了2,799,434股（+129.4%）的持仓。
- FRONTIER CAPITAL MANAGEMENT CO LLC 在2024年第三季度从其投资组合中移除了1,836,873股（-100.0%）。
- MACQUARIE GROUP LTD 在2024年第三季度从其投资组合中移除了1,567,013股（-100.0%）。
- D. E. SHAW & CO., INC. 在2024年第三季度向其投资组合中增加了1,476,508股（+307.3%）。
- STEPHENS INVESTMENT MANAGEMENT GROUP LLC 在2024年第三季度从其投资组合中移除了1,371,561股（-100.0%）。
- ARROWSTREET CAPITAL, LIMITED PARTNERSHIP 在2024年第三季度向其投资组合中增加了1,099,216股（+2058.1%）。
- 摩根士丹利 在2024年第三季度向其投资组合中增加了1,079,724股（+209.2%）。
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
要跟踪对冲基金的股票投资组合，请查看Quiver Quantitative的机构持有情况仪表。
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.
本文不是金融建议。有关更多信息，请参阅Quiver Quantitative的免责声明。
